Screener
Myriad Genetics MYGN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $420.79M.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
FAQ
- What is Myriad Genetics's market capitalization?
- Myriad Genetics (MYGN) reported market capitalization of $420.79M in Q1 2026.
- How has Myriad Genetics's market capitalization changed year-over-year?
- Myriad Genetics's market capitalization decreased by 48.0% year-over-year, from $809.91M to $420.79M.
- What is the long-term trend for Myriad Genetics's market capitalization?
- Over 5 years (2020 to 2025), Myriad Genetics's market capitalization has grown at a -18.3% compound annual growth rate (CAGR), from $1.58B to $573.26M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Myriad Genetics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude